How Patients View Probiotics
- 1 February 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Clinical Gastroenterology
- Vol. 46 (2), 138-144
- https://doi.org/10.1097/mcg.0b013e318225f545
Abstract
Background Patients with inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) have access to a growing number of probiotic products marketed to improve digestive health. It is unclear how patients make decisions about probiotics and what role they expect their gastroenterologists to play as they consider using probiotics. Understanding patients’ knowledge, attitudes and expectations of probiotics may help gastroenterologists engage patients in collaborative discussions about probiotics. Study Focus groups were conducted with patients with IBD and IBS at the Cleveland Clinic, Mayo Clinic, and Johns Hopkins University. Inductive analytic methods were used to identify common themes and draw interpretations from focus group narratives. Results One hundred thirty-six patients participated in 22 focus groups between March and August 2009. Patients viewed probiotics as an appealing alternative to pharmaceutical drugs and understood probiotics as a more “natural,” low-risk therapeutic option. Many patients were hesitant to use them without consulting their gastroenterologists. Patients would weigh the risks and benefits of probiotics, their disease severity and satisfaction with current treatments when considering probiotic use. Conclusions Patients are interested in probiotics but have many unanswered questions about their use. Our findings suggest that patients with IBD and IBS will look to gastroenterologists and other clinicians as trustworthy advisors regarding the utility of probiotics as an alternative or supplement to pharmaceutical drugs. Gastroenterologists and other clinicians who care for patients with these diseases should be prepared to discuss the potential benefits and risks of probiotics and assist patients in making informed decisions about their use.Keywords
This publication has 15 references indexed in Scilit:
- Probiotic Dairy Products as Functional FoodsComprehensive Reviews in Food Science and Food Safety, 2010
- Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitisPublished by Wiley ,2010
- Probiotics as Therapy in GastroenterologyJournal of Clinical Gastroenterology, 2010
- The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative ColitisClinical Gastroenterology and Hepatology, 2009
- Helping Patients Make Informed Choices About Probiotics: A Need for ResearchThe American Journal of Gastroenterology, 2009
- Recommendations for Probiotic Use—2008Journal of Clinical Gastroenterology, 2008
- Probiotics in the United StatesClinical Infectious Diseases, 2008
- Probiotics for induction of remission in ulcerative colitisPublished by Wiley ,2007
- Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: Perceived stress is a potential indicator for CAM useComplementary Therapies in Medicine, 2007
- Probiotics for maintenance of remission in Crohn's diseaseCochrane Database of Systematic Reviews, 2006